Showing results (11-20 of 298) with videos related to
Sort By:
Pageof 30
Croatian Medical Journal|August 23, 2012
Personalized medicine - where do we stand? Pouring some water into wine: a realistic perspectiveUrsula Gundert-Remy, Aleksandar Dimovski, Srećko GajovićZeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 19, 2013
[The costs of new drugs compared to current standard treatment]Mariam Ujeyl, Claudia Schlegel, Ursula Gundert-RemyArchives of Toxicology|February 14, 2013
Functional UDP-glucuronyltransferase 2B15 polymorphism and bisphenol A concentrations in blood: results from physiologically based kinetic modellingFalko Partosch, Hans Mielke, Ursula Gundert-RemyToxicology Letters|December 25, 2012
Commentary: dermal penetration of bisphenol A--consequences for risk assessmentUrsula Gundert-Remy, Hans Mielke, Ulrike BernauerToxicology Letters|October 15, 2017
Preliminary data on citrinin kinetics in humans and their use to estimate citrinin exposure based on biomarkersGisela H Degen, Nurshad Ali, Ursula Gundert-RemyPharmaceutics|April 28, 2023
Infant Exposure to Antituberculosis Drugs via Breast Milk and Assessment of Potential Adverse Effects in Breastfed Infants: Critical Review of DataEngi Abdelhady Algharably, Reinhold Kreutz, Ursula Gundert-RemyToxicology|August 2, 2005
Acute inhalative exposure assessment: derivation of guideline levels with special regard to sensitive subpopulations and time scalingHans Mielke, Anna Gundert, Klaus Abraham, et al.Deutsches Arzteblatt International|March 20, 2012
New drugs: evidence relating to their therapeutic value after introduction to the marketMariam Ujeyl, Claudia Schlegel, Siegbert Walter, et al.Archives of Toxicology|January 4, 2019
Importance of in vitro conditions for modeling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE)Engi Abdel Hady Algharably, Reinhold Kreutz, Ursula Gundert-RemyFrontiers in Pharmacology|February 7, 2019
Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-FeedingEstella Dora Germaine Garessus, Hans Mielke, Ursula Gundert-RemyPageof 30